FDA NDC Directory · JSON-LD · Markdown

hydroxyzine pamoate

NDC 70934-962 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerDenton Pharma, Inc. DBA Northwind Pharmaceuticals
Marketing categoryAbbreviated NDA (generic) · App ANDA087479
Dosage form / routeCAPSULE · ORAL
Active ingredientsHYDROXYZINE PAMOATE (25 mg/1)
Marketing started20220324
Marketing ended20260531
Package count1

External sources

Source: openFDA. Public-domain (CC0).